1.NMDA receptors in prelimbic cortex neurons projecting to paraventricular nucleus of the thalamus are associated with morphine withdrawal memory retrieval.
Chen-Shan CHU ; Ya-Xian WEN ; Qian-Ru SHEN ; Bin LAI ; Ming CHEN ; Ping ZHENG
Acta Physiologica Sinica 2024;76(6):917-926
At present, the problem of drug addiction treatment mainly lies in the high relapse rate of drug addicts. Addictive drugs will bring users a strong sense of euphoria and promote drug seeking. Once the drug is withdrawn, there will be withdrawal symptoms such as strong negative emotions and uncomfortable physical reactions. The recurrence of context-induced withdrawal memory is an important reason for drug relapse. Our previous study has shown increased c-Fos expression in prelimbic cortex (PrL) neurons projecting to paraventricular nucleus of the thalamus (PVT) (PrL-PVT) during conditioned context-induced retrieval of morphine withdrawal memory. However, whether PrL-PVT neurons are involved in withdrawal memory retrieval and the underlying molecular mechanisms remain unknown. In this study, we used conditioned place aversion (CPA) model combined with in vivo calcium signal recording, chemogenetics and nucleus drug injection methods to investigate the role and molecular mechanism of PrL-PVT neurons in retrieval of morphine withdrawal memory. The results showed that the calcium signals of PrL-PVT neurons were significantly enhanced by withdrawal-related context; Inhibition of PrL-PVT neurons blocked the conditioned context-induced morphine withdrawal memory retrieval; Activation of PrL-PVT neurons caused animals to escape from the context; After the inhibition of NMDA receptors in the PrL, withdrawal-related context failed to increase c-Fos and Arc expressions in PrL-PVT neurons. The above results suggest that NMDA receptors in PrL-PVT neurons are associated with retrieval of morphine withdrawal memory. This study is of great significance for further understanding the neural circuit mechanism of withdrawal memory retrieval as well as the intervention and prevention of drug relapse.
Animals
;
Substance Withdrawal Syndrome/physiopathology*
;
Morphine/adverse effects*
;
Neurons/physiology*
;
Receptors, N-Methyl-D-Aspartate/metabolism*
;
Male
;
Rats
;
Paraventricular Hypothalamic Nucleus/metabolism*
;
Memory
;
Rats, Sprague-Dawley
;
Morphine Dependence/physiopathology*
;
Midline Thalamic Nuclei/physiology*
;
Neural Pathways/metabolism*
2.Unique Pharmacology, Brain Dysfunction, and Therapeutic Advancements for Fentanyl Misuse and Abuse.
Ying HAN ; Lu CAO ; Kai YUAN ; Jie SHI ; Wei YAN ; Lin LU
Neuroscience Bulletin 2022;38(11):1365-1382
Fentanyl is a fully synthetic opioid with analgesic and anesthetic properties. It has become a primary driver of the deadliest opioid crisis in the United States and elsewhere, consequently imposing devastating social, economic, and health burdens worldwide. However, the neural mechanisms that underlie the behavioral effects of fentanyl and its analogs are largely unknown, and approaches to prevent fentanyl abuse and fentanyl-related overdose deaths are scarce. This review presents the abuse potential and unique pharmacology of fentanyl and elucidates its potential mechanisms of action, including neural circuit dysfunction and neuroinflammation. We discuss recent progress in the development of pharmacological interventions, anti-fentanyl vaccines, anti-fentanyl/heroin conjugate vaccines, and monoclonal antibodies to attenuate fentanyl-seeking and prevent fentanyl-induced respiratory depression. However, translational studies and clinical trials are still lacking. Considering the present opioid crisis, the development of effective pharmacological and immunological strategies to prevent fentanyl abuse and overdose are urgently needed.
Humans
;
Fentanyl/therapeutic use*
;
Opioid-Related Disorders/drug therapy*
;
Drug Overdose/prevention & control*
;
Analgesics, Opioid/adverse effects*
;
Vaccines/therapeutic use*
;
Brain
3.Abuse of Pharmaceutical Drugs and Its Prevention.
Journal of Forensic Medicine 2021;37(6):788-795
Abuse of pharmaceutical drugs is a major public health and social problem worldwide. Mostly abused drugs mainly include opioids such as morphine, tramadol, methadone and fentanyl, sedative-hypnotics such as benzodiazepines and non-benzodiazepines, and central stimulants such as Ritalin (methylphenidate), Adderall (amphetamine and dextroamphetamine) and modafinil. Abuse of pharmaceutical drugs not only causes direct damage to multiple systems of the body, but also significantly increases risks of mental and physical diseases, imposing a heavy burden on individuals, families and society. Therefore, the prevention and control of pharmaceutical drug abuse are of vital importance. The Chinese government has taken strict administration measures for pharmaceutical drugs with abuse risk. However, confronting endless new drugs and changing abuse trends, it is necessary to further strengthen management and prevention of pharmaceutical drugs, monitor the trend of abuse, establish rapid response mechanisms, popularize relevant knowledge, and develop specific therapeutic drugs and intervention means, in order to promote prevention and treatment of pharmaceutical drug abuse.
Analgesics, Opioid/adverse effects*
;
Central Nervous System Stimulants/adverse effects*
;
Humans
;
Illicit Drugs/adverse effects*
;
Substance-Related Disorders/prevention & control*
4.Cannabis use among the drug users with compulsory detained detoxification treatment in China.
Wen Jun TANG ; Hao Xiang TANG ; Yi XING
Journal of Peking University(Health Sciences) 2020;52(3):541-546
OBJECTIVE:
To explore the epidemic situation of cannabis use among drug users with compulsory detained detoxification treatment in China.
METHODS:
Using the data from the Drug Abuse Population Estimation in the Key Cities of the Ministry of Public Security, we analyzed the sociodemographic characteristics and substance use of cannabis abusers with compulsory detained detoxification treatment in 55 provincial capital cities and key cities of China. Chi-square test, Fisher exact test and Kruskal-Wallis rank sum test were used to compare the prevalence of cannabis, heroin, synthetic and mixed drug use among patients with detoxification treatment, as well as the differences in polydrug use and areas among cannabis users.
RESULTS:
In the study, 25 366 drug users with compulsory detained detoxification treatment were recruited, of whom 2.2% (546/25 366) used cannabis in the previous year before the treatment. The proportion of males was 83.5%, and the proportion of ethnic minorities was 41.0%. Those who received junior high school education or above accounted for 30.8%, and the unemployed accounted for 44.1%. The average age was (33.3±8.2) years, the average age of beginning drug use was (24.8±7.7) years, and the average duration between the first drug abuse and first detoxification treatment was (5.4±4.6) years. The prevalence of cannabis use was higher among those drug users who were 35-year-old and younger, ethnic minorities, employees and residents in Xinjiang. Of the cannabis users, 91.4% used polydrug, 13.6% combined with heroin alone, 42.1% combined with synthetic drugs alone and 35.7% combined with both of heroin and synthetic drugs. Of the cannabis users, 49.6% came from 3 regions: Xinjiang Uygur Autonomous Region, Jiangsu Province and Shanghai City. The cannabis users in Xinjiang had a high proportion of ethnic minorities who received junior high school education and below. Moreover, 79.6% of them combined cannabis use with heroin. The cannabis users in Jiangsu, Zhejiang and Shanghai areas had a higher proportion of ethnic Han who received better education (high school and above). Moreover, 92.7% of them combined cannabis use with methamphe-tamine.
CONCLUSION
The prevalence of cannabis use among the population with compulsory detained detoxification treatment is higher than that among drug users under surveillance, but there are obvious regional cluster effect and high possibility of polydrug abuse. Thus, it's important to strengthen the monitoring of cannabis use, to increase the control of cannabis and to formulate China's anti-cannabis policy among different population.
Adolescent
;
Adult
;
Cannabis
;
China
;
Drug Users
;
Female
;
Heroin Dependence
;
Humans
;
Male
;
Opiate Substitution Treatment
;
Young Adult
5.Intra-nucleus accumbens shell injection of baclofen blocks the reconsolidation of conditioned place preference in morphine-addicted mice.
Ruo-Chen WANG ; Li-Fei XIAO ; Chun ZHANG ; Tao SUN ; Kui-Sheng SUN
Acta Physiologica Sinica 2020;72(2):255-261
Preclinical studies suggest that the GABA receptor is a potential target for treatment of substance use disorders. Baclofen (BLF), a prototypical GABA receptor agonist, is the only specific GABA receptor agonist available for application in clinical addiction treatment. The nucleus accumbens shell (AcbSh) is a key node in the circuit that controls reward-directed behavior. However, the relationship between GABA receptors in the AcbSh and memory reconsolidation was unclear. The aim of this study was to investigate the effect of intra-AcbSh injection of BLF on the reconsolidation of morphine reward memory. Male C57BL/6J mice were used to establish morphine conditioned place preference (CPP) model and carry out morphine reward memory retrieval and activation experiment. The effects of intra-AcbSh injection of BLF on morphine-induced CPP, reinstatement of CPP and locomotor activity were observed after environmental cues activating morphine reward memory. The results showed that intra-AcbSh injection of BLF (0.06 nmol/0.2 μL/side or 0.12 nmol/0.2 μL/side), rather than vehicle or BLF (0.01 nmol/0.2 μL/side), following morphine reward memory retrieval abolished morphine-induced CPP by disrupting its reconsolidation in mice. Moreover, this effect persisted for more than 14 days, which was not reversed by a morphine priming injection. Furthermore, intra-AcbSh injection of BLF without morphine reward memory retrieval had no effect on morphine-associated reward memory. Interestingly, administration of BLF into the AcbSh had no effect on the locomotor activity of mice during testing phase. Based on these results, we concluded that intra-AcbSh injection of BLF following morphine reward memory could erase morphine-induced CPP by disrupting its reconsolidation. Activating GABA receptor in AcbSh during drug memory reconsolidation may be a potential approach to prevent drug relapse.
Animals
;
Baclofen
;
administration & dosage
;
Conditioning, Classical
;
GABA-B Receptor Agonists
;
administration & dosage
;
Locomotion
;
Male
;
Memory
;
Mice
;
Mice, Inbred C57BL
;
Morphine
;
Nucleus Accumbens
;
drug effects
;
Opioid-Related Disorders
;
Reward
6.MicroRNA-132 in the Adult Dentate Gyrus is Involved in Opioid Addiction Via Modifying the Differentiation of Neural Stem Cells.
Meng JIA ; Xuewei WANG ; Haolin ZHANG ; Can YE ; Hui MA ; Mingda YANG ; Yijing LI ; Cailian CUI
Neuroscience Bulletin 2019;35(3):486-496
MicroRNA-132 (miR-132), a small RNA that regulates gene expression, is known to promote neurogenesis in the embryonic nervous system and adult brain. Although exposure to psychoactive substances can increase miR-132 expression in cultured neural stem cells (NSCs) and the adult brain of rodents, little is known about its role in opioid addiction. So, we set out to determine the effect of miR-132 on differentiation of the NSCs and whether this effect is involved in opioid addiction using the rat morphine self-administration (MSA) model. We found that miR-132 overexpression enhanced the differentiation of NSCs in vivo and in vitro. Similarly, specific overexpression of miR-132 in NSCs of the adult hippocampal dentate gyrus (DG) during the acquisition stage of MSA potentiated morphine-seeking behavior. These findings indicate that miR-132 is involved in opioid addiction, probably by promoting the differentiation of NSCs in the adult DG.
Animals
;
Cell Differentiation
;
Cell Line, Tumor
;
Dentate Gyrus
;
metabolism
;
Gene Expression Regulation
;
Male
;
MicroRNAs
;
metabolism
;
Neural Stem Cells
;
metabolism
;
Opioid-Related Disorders
;
metabolism
;
Rats, Sprague-Dawley
7.Visual and Auditory Reaction Times of Patients with Opioid Use Disorder
Psychiatry Investigation 2019;16(8):602-606
OBJECTIVE: Reaction time is defined as the time from the start of a stimulus to the start of the voluntary movement. Time plays an important role in undertaking daily living activities. Reaction time is an important factor in respect of both quality of life and of capabilities demonstrated in the work environment. Alcohol and some addictive substances have effect on RT. The aim of this study was to compare the visual and auditory reaction times of patients with opioid use disorder with healthy control subjects. METHODS: The study was applied to two groups as the opioid use disorder group and the control group. A Sociodemographic and Clinical Data Form was prepared for each patient including age, gender, marital status and education level. Using a computer program the response to visual screen color change (red/blue) and to an auditory ‘beep’ sound of the computer system were recorded. The Student’s t-test was applied as a statistical method. RESULTS: The results showed longer reaction times in the patients with opioid use disorder. CONCLUSION: To add improving reaction time approaches in opioid use disorder treatment may contribute to treatment by increasing quality of life and work performance.
Activities of Daily Living
;
Computer Systems
;
Drug Users
;
Education
;
Heroin Dependence
;
Humans
;
Marital Status
;
Methods
;
Mortuary Practice
;
Opioid-Related Disorders
;
Quality of Life
;
Reaction Time
;
Work Performance
8.Increased Neutrophil-lymphocyte and Platelet-lymphocyte Ratios in Male Heroin Addicts: A Prospective Controlled Study.
Erdinc CICEK ; Başak DEMIREL ; Ismet Esra CICEK ; Aslı Seda KIRAÇ ; Ibrahim EREN
Clinical Psychopharmacology and Neuroscience 2018;16(2):190-196
OBJECTIVE: The neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are markers that can determine the presence of systemic inflammatory response. In this study, we examined the NLR and PLR levels in patients with heroin dependence compared to healthy controls. METHODS: The study sample included 90 male patients with heroin dependence aged 18 to 45 years and 60 healthy subjects who had similar socio-demographic characteristics as the patient group. The diagnoses of heroin dependence and other Axis I psychiatric disorders in the patient and control groups were screened with the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID-I). The extent of heroin addiction was assessed with the Addiction Severity Index (ASI). RESULTS: The mean NLR and PLR levels of patients with heroin dependence were significantly higher than the control subjects (p=0.031 and p < 0.001, respectively). Positive correlations were found between NLR, PLR and duration of the disorder. CONCLUSION: Our results indicate that inflammatory processes may play a role in the pathophysiology of heroin dependence.
Diagnosis
;
Diagnostic and Statistical Manual of Mental Disorders
;
Healthy Volunteers
;
Heroin Dependence
;
Heroin*
;
Humans
;
Male*
;
Prospective Studies*
9.Acupuncture and the Opioid Epidemic in America.
Chinese journal of integrative medicine 2018;24(5):323-327
The opioid epidemic has become a signifificant public health crisis in the United States of America. This crisis has elicited a response at high levels of governmental and health care organizations including the American College of Physicians, the Food and Drug Administration, the Joint Commission, the National Academies of Science, Engineering and Medicine, the National Association of Attorneys General, and the White House. In various ways, these organizations have recognized that acupuncture can play an important role in dealing with the opioid epidemic. This paper presents and analyzes the scientifific evidence supporting the effificacy of acupuncture in regard to opioid addiction.
Acupuncture Therapy
;
Analgesics, Opioid
;
adverse effects
;
Clinical Trials as Topic
;
Epidemics
;
Humans
;
Opioid-Related Disorders
;
epidemiology
;
therapy
10.Successful Treatment with Transdermal Buprenorphine Patch in Opioid-Dependent Cancer Patients: Case Series.
Se Il GO ; Jung Hoon KIM ; Gyeong Won LEE ; Jung Hun KANG
Korean Journal of Hospice and Palliative Care 2018;21(4):152-157
Opioid aberrant behavior is an emerging problem as strong opioid is increasingly used to alleviate cancer pain in patients with cancer. Although the treatment of opioid addiction and physical dependence for non-cancer pain is well known, few studies have been conducted with cancer patients, particularly in the Korean population. Presented here are ten cases of cancer patients who were physically dependent on strong opioid and successfully treated with a partial mu-opioid receptor agonist, buprenorphine. This is the first report showing the efficacy of transdermal buprenorphine as a treatment for physical dependence on opioid medication in cancer patients.
Analgesics, Opioid
;
Buprenorphine*
;
Humans
;
Opioid-Related Disorders

Result Analysis
Print
Save
E-mail